Creatine in 2026: The Science Hasn't Changed. Everything Else Has.
Creatine monohydrate's science is settled. What's shifting in 2026 is everything around it: who supplies it, what format it comes in, and whether consumers can trust the label.
News
Reporting, analysis, and commentary on supplement brands, retailers, distributors, and compliance shifts.
Creatine monohydrate's science is settled. What's shifting in 2026 is everything around it: who supplies it, what format it comes in, and whether consumers can trust the label.
Vitafoods Europe 2026 wrapped in Barcelona on May 7. Here's what the sports and active nutrition industry needs to know from the show floor.
Approved campaign assets do not become easier to use just because they are approved. Brands still need a delivery model that makes the right files easy to retrieve without email chains and version confusion.
Distributors rarely need more promises from brands. They need current product content, assets, and support files they can retrieve and use without another round of follow-up emails.
Many joint business plans do not fail because the commercial idea was wrong. They fail because the brand side of execution still depends on resend work, scattered assets, and unclear versions.
Creatine built its market on price. Now it's being sold in pharmacies and wellness brands to buyers who've never touched a protein powder. The category running two conversations at once.
News
Reporting, analysis, and commentary on supplement brands, retailers, distributors, and compliance shifts.
Creatine monohydrate's science is settled. What's shifting in 2026 is everything around it: who supplies it, what format it comes in, and whether consumers can trust the label.
Vitafoods Europe 2026 wrapped in Barcelona on May 7. Here's what the sports and active nutrition industry needs to know from the show floor.
Approved campaign assets do not become easier to use just because they are approved. Brands still need a delivery model that makes the right files easy to retrieve without email chains and version confusion.
Distributors rarely need more promises from brands. They need current product content, assets, and support files they can retrieve and use without another round of follow-up emails.
Many joint business plans do not fail because the commercial idea was wrong. They fail because the brand side of execution still depends on resend work, scattered assets, and unclear versions.
Creatine built its market on price. Now it's being sold in pharmacies and wellness brands to buyers who've never touched a protein powder. The category running two conversations at once.